Indaptus Therapeutics, Inc. INDP
3.85
(0.15)
(3.75%)
as of 25 Sep
- Market cap
- $606.8M
- P/E
- 0.0×
Follow INDP
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
2.88 | 1.51 | 2.34 | 19.48 |
Net Debt/EBITDA |
2.20 | 1.04 | 0.69 | 6.39 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 0.39 | 2.76 | 1.07 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(2.58) | (3.30) | (0.64) | (0.02) | |
Cash per Share |
5.84 | 8.81 | 0.14 | 0.10 | |
Shareholders Equity per Share |
4.62 | 3.26 | 0.11 | 0.10 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.62 | 3.26 | 0.11 | 0.10 | |
Free Cash Flow |
(2.57) | (3.19) | (7.01) | (1.93) | |
Working Capital |
4.20 | 3.15 | 1.25 | 11.37 | |
Net Current Asset Value |
4.20 | 3.15 | 1.25 | 11.37 | |
| Other line items | |||||
Quick Ratio |
2.61 | 1.38 | 1.61 | 18.77 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.58) | (3.30) | (0.64) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
2.18 | 4.73 | 1.74 | 1.30 | |
Average Assets |
7.54 | 8.32 | 3.80 | 9.41 | |
Average Common Equity |
5.30 | 3.54 | 2.02 | 4.85 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates